A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs. - Georgi I. Kapitanov; Jeffrey R. Chabot; Jatin Narula; Mahua Roy; Hendrik Neubert; Joe Palandra; Vahid Farrokhi; Jay S. Johnson; Robert Webster; Hannah M. Jones (Frontiers Bioinform., 2021)